Mark Lansdown
Mark Lansdown
Unknown affiliation
Verified email at leedsth.nhs.uk
Title
Cited by
Cited by
Year
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen
J Adams, PJ Carder, S Downey, MA Forbes, K MacLennan, V Allgar, ...
Cancer research 60 (11), 2898-2905, 2000
4602000
Breast cancer cell lines: friend or foe?
SE Burdall, AM Hanby, MRJ Lansdown, V Speirs
Breast cancer research 5 (2), 1-7, 2003
3922003
Gastric cancer: a curable disease in Britain.
HM Sue-Ling, D Johnston, IG Martin, MF Dixon, MR Lansdown, ...
British Medical Journal 307 (6904), 591-596, 1993
3031993
Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model
GP Skliris, K Munot, SM Bell, PJ Carder, S Lane, K Horgan, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
2502003
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma.
M Lansdown, P Quirke, MF Dixon, AT Axon, D Johnston
Gut 31 (9), 977-983, 1990
1831990
Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism
CN Patel, HM Salahudeen, M Lansdown, AF Scarsbrook
Clinical radiology 65 (4), 278-287, 2010
1772010
Oestrogen receptor β: what it means for patients with breast cancer
V Speirs, PJ Carder, S Lane, D Dodwell, MRJ Lansdown, AM Hanby
The lancet oncology 5 (3), 174-181, 2004
1632004
Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations
RE Coleman, WW Bolten, M Lansdown, S Dale, C Jackisch, D Merkel, ...
Cancer treatment reviews 34 (3), 275-282, 2008
1262008
Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling?
GP Skliris, PJ Carder, MRJ Lansdown, V Speirs
British journal of cancer 84 (8), 1095-1098, 2001
1102001
Sentinel lymph node biopsy in male breast cancer patients
A Goyal, K Horgan, M Kissin, C Yiangou, M Sibbering, M Lansdown, ...
European Journal of Surgical Oncology (EJSO) 30 (5), 480-483, 2004
862004
Teaching laparoscopic surgery: the need for guidelines
CMS Royston, MRJ Lansdown, WA Brough
Bmj 308 (6935), 1023-1025, 1994
761994
Steroid hormone receptor expression in male breast cancer
CE Murphy, PJ Carder, MRJ Lansdown, V Speirs
European Journal of Surgical Oncology (EJSO) 32 (1), 44-47, 2006
752006
The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment
S Duffy, TL Jackson, M Lansdown, K Philips, M Wells, S Pollard, G Clack, ...
Human reproduction 21 (2), 545-553, 2006
742006
Culture, attitude and knowledge about breast cancer and preventive measures: a qualitative study of South Asian breast cancer patients in the UK
G Karbani, JN Lim, J Hewison, K Atkin, K Horgan, M Lansdown, CE Chu
Asian Pac J Cancer Prev 12 (6), 1619-26, 2011
692011
Helicobacter gastritis and intestinal metaplasia in a gastric cancer family
N Scott, R Diament, V Murday, M McMahon, M Lansdown, B Rathbone, ...
The Lancet 335 (8691), 728, 1990
671990
For better, for worse?: a review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy
D Mort, F MRCGP
NCEPOD, 2008
55*2008
For better, for worse?: a review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy
D Mort, F MRCGP
NCEPOD, 2008
55*2008
Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis
ZZR Hamady, N Mather, MR Lansdown, L Davidson, KA Maclennan
European Journal of Surgical Oncology (EJSO) 31 (1), 74-77, 2005
472005
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
S Potter, EJ Conroy, RI Cutress, PR Williamson, L Whisker, S Thrush, ...
The Lancet Oncology 20 (2), 254-266, 2019
382019
Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression–Implications for the practising oncologist
R Gahlaut, A Bennett, H Fatayer, BJ Dall, N Sharma, G Velikova, T Perren, ...
European Journal of Cancer 60, 40-48, 2016
382016
The system can't perform the operation now. Try again later.
Articles 1–20